News

People who consistently have higher depressive symptoms may be at higher risk for a stroke, according to new research. But stroke risk does not increase in those with decreasing severity of symptoms over time, even if they had high depressive symptoms early on. Past studies show a possible link between depression and the risk of [...]

The national roll-out follows a successful pilot project to enable employers to offer increased support

Researchers have developed a therapeutic method for harnessing the body’s immune system to protect against brain damage. They have produced a targeted delivery system for boosting the numbers of specialised anti-inflammatory immune cells specifically within the brain to restrict brain inflammation and damage. The brain-specific delivery system protected against brain cell death following brain injury, [...]

A new study supports the notion that patients with type two diabetes should be divided into subgroups and given individualised treatment. The Lund University research published in Diabetes Care demonstrates that there are distinct epigenetic differences between separate groups of patients with type two diabetes. The epigenetic markers are also associated with different risks of developing [...]

NR Times speaks to experts at St Andrew's Healthcare about Huntington's Disease and its impact on people and families

The drug gabapentin, currently prescribed to control seizures and reduce nerve pain, may enhance recovery of movement after a stroke. It does that by helping neurons on the undamaged side of the brain take up the signalling work of lost cells, new research in mice suggests. The experiments mimicked ischemic stroke in humans, which occurs [...]

A US stroke organisation has awarded researchers a huge cash grant to test how well an experimental drug helps with recovery following an acute ischemic stroke. When administered soon after the onset of acute ischemic stroke, current approved treatments for the condition can dramatically improve patient outcomes. However, not all patients are cured, and approved [...]

Scientists have described a new preclinical drug that has the potential to combat depression, brain injury and diseases that impair cognition. The drug, which is brain-permeable, acts to inhibit the kinase enzyme. Cdk5 is a crucial regulator of signalling in brain neurons. Over three decades of study, it has been implicated in neuropsychiatric and neurodegenerative conditions, [...]

Stroke hospitalisations for younger adults – along with the cardiovascular risk factors associated with them – have risen since 2007, preliminary new research shows. But the chances of people under age 45 dying from a stroke in the hospital have dropped. The increase in hospitalisations was higher for women and for white and Hispanic adults, [...]

The change-making company secured the best possible CQC rating at first time of inspection